1. Home
  2. KRO vs MLTX Comparison

KRO vs MLTX Comparison

Compare KRO & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

HOLD

Current Price

$7.81

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

SELL

Current Price

$11.90

Market Cap

863.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
KRO
MLTX
Founded
1916
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
863.0M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
KRO
MLTX
Price
$7.81
$11.90
Analyst Decision
Hold
Buy
Analyst Count
2
15
Target Price
$8.50
★ $28.54
AVG Volume (30 Days)
315.0K
★ 1.8M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
★ 2.62%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.09
N/A
Revenue
★ $1,859,400,000.00
N/A
Revenue This Year
$11.05
N/A
Revenue Next Year
$1.77
N/A
P/E Ratio
$85.22
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.08
$9.37
52 Week High
$9.17
$23.29

Technical Indicators

Market Signals
Indicator
KRO
MLTX
Relative Strength Index (RSI) 50.98 52.60
Support Level $7.43 $9.73
Resistance Level $7.89 $19.32
Average True Range (ATR) 0.25 0.74
MACD 0.02 0.30
Stochastic Oscillator 69.23 61.95

Price Performance

Historical Comparison
KRO
MLTX

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: